2010
 

New revolutionary method of early cancer diagnostics

INGENIOUS INVENTION OF PROF DR BOGDAN MAGLIĆ

In Huston, USA, at the First Global Congress on Nano Medicine, a revolutionary novelty in early cancer diagnostics by means of a diagnostic probe – Oncosensor was presented. Multidisciplinary scientific team that consisted of physicists, biologists and physicians was headed by a distinguished American scientist of Serbian origin and a member of the Serbian Academy of Sciences and Arts Dr Bogdan Maglić. .
Oncosensor is a device that detects in a completely new and extremely simple manner malignant cells just after they emerge. It is a painless method of cancer diagnostics that detects malign cells without any operations, intravenous fluid and biopsy, with incomparably higher preciseness than the existing so-called „imagers”. The imagers have recorded an unacceptable percentage of wrong diagnoses in differentiating between healthy and malignant tumors. However, Oncosensor's specificity reaches 98%, which is better than surgical biopsy.
Oncosensor sets the diagnosis by bombarding DNA nucleotides and tissues with femto-neutrons of incredible speed that detect oxygen difference between a tumor and the adjacent normal tissue. Hypoxic cancerous tumors contain 50% to 90% less oxygen than healthy tissue. The device detects the oxygen difference between malignant and healthy tissue and accordingly diagnoses cancer. The method is named Differential Femto Oximetry, and the patented diagnostic probe – Oncosensor, and they are developed through collaboration between the California Science & Engineering Corporation (CALSEC) and University of California Irvine College of Medicine.
Prof Dr. Nisar Syed of The Long Beach Cancer Institute and Chancellor of American College of Radiation Oncology said at the aforementioned Congress that Oncosensor has the potential to instantly facilitate eradication of malign tumors by heat treatment known as hyperthermia, because it directs the surgeon to the area with the least oxygenated tissue.
The project co-author Orhan Nalcioglu, Director of the Center for Functional Onco Imaging of the UCI College of Medicine said at the Congress in Huston that the objective of further researches will be the treatment of malignant diseases by this method. The experiment will be carried out by making animals inhale Carbogen, an oxygen-enriched harmless gas whereby malignant tumors would be nourished with oxygen and transformed into healthy tissue. This is the emergence of FEMTOMEDICINE – new discipline of biomedical sciences which has been dealt with for years by the team led by Dr. Bogdan Maglić, and the obtained knowledge was originally utilized for military purposes.
„Femto Oximetry“ is a method that has also the potential to forewarn of a stroke, Alzheimer disease and cardiovascular diseases which are also marked by oxygen insufficiency.
Dr. Maglić is a Chief Technology Officer of the scientific center CALSEC in California, and a renowned American journal “Fast Company“ included him into “50 Champions of Innovation“.
CALSEC scientific team includes several other Serbian scientists, among them Aleksandar Šuvaković and Ana Radović, molecular biologist. During his engagement in this globally important project Dr. Maglić maintained constant consultations with his colleagues in the Serbian Academy of Sciences and Arts.
On the occasion of this revolutionary invention, “CNN” TV network broadcast a 5-minute film as part of its program called Avant-garde Diagnostic Technologies.

 

 

PlanPlus